Evidence map›Paper›PMID 41063627›Full record

ArticleClinical and translational medicine2025

CircHPCAL1 promotes the progression of pancreatic cancer via the regulation of STEAP2.

Xiaomeng He, Yang Di, Lixiang Sun, Wenchuan Wu, Zehuan Li, Qiuyue Li, Shanshan Liu, Mengting Luo, Xin Zhang, Li Xu and 4 more

Abstract read
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaomeng HeCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Yang DiDepartment of Pancreatic Surgery, Pancreatic Disease Institute, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Lixiang SunCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Wenchuan WuDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Zehuan LiDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Qiuyue LiShanghai Public Health Clinical Centre, Fudan University, Shanghai, China.
Shanshan LiuShanghai Public Health Clinical Centre, Fudan University, Shanghai, China.
Mengting LuoCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Xin ZhangCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Li XuShanghai Public Health Clinical Centre, Fudan University, Shanghai, China.
Xiaoyan ZhangXiamen Key Laboratory of Biotherapy, Xiamen, China.
Jianqing XuXiamen Key Laboratory of Biotherapy, Xiamen, China.
Christopher CorpeDepartment of Nutritional Science, King's College London, London, UK.
Jin WangCentral Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.ORCID https://orcid.org/0000-0002-0062-2489

Funding

Fujian Provincial Health and Wellness Science and Technology Program 2024GGB24Fujian Provincial Natural Science Foundation of China 2024J011432Science and Technology Plan Project of Xiamen 3502Z20224012Xiamen Global Talents Fund Project
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41063627
PMCPMC12508615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.